Back to Search Start Over

Wet Age-Related Macular Degeneration Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | IVERIC bio, Ribomic, Curacle, Bio-Thera

Source :
M2 Presswire. May 16, 2024
Publication Year :
2024

Abstract

M2 PRESSWIRE-May 16, 2024-: Wet Age-Related Macular Degeneration Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | IVERIC bio, Ribomic, Curacle, Bio-Thera (C)1994-2024 [...]

Subjects

Subjects :
Medical research -- Reports
Medicine, Experimental -- Reports
Business -- Research
Axitinib -- Reports
Macular degeneration -- Reports
Clinical trials -- Reports
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 Presswire
Publication Type :
News
Accession number :
edsgcl.794012563

Tools

Authors Abstract Subjects Details